Melosky B - Search Results

1

Bevacizumab biosimilars: scientific justification for extrapolation of indications.

Melosky B, Reardon DA, Nixon AB, Subramanian J, Bair AH, Jacobs I. Melosky B, et al. Future Oncol. 2018 Oct;14(24):2507-2520. doi: 10.2217/fon-2018-0051. Epub 2018 Apr 25. Future Oncol. 2018. PMID: 29690784 Free article. Review.

2

Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations.

Sun A, Abdulkarim B, Blais N, Greenland J, Louie AV, Melosky B, Schellenberg D, Snow S, Liu G. Sun A, et al. Among authors: melosky b. Lung Cancer. 2023 May;179:107166. doi: 10.1016/j.lungcan.2023.03.002. Epub 2023 Mar 9. Lung Cancer. 2023. PMID: 36944282 Free article. Review.

3

EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: outcomes in Asian populations.

Kim ES, Melosky B, Park K, Yamamoto N, Yang JC. Kim ES, et al. Among authors: melosky b. Future Oncol. 2021 Jun;17(18):2395-2408. doi: 10.2217/fon-2021-0195. Epub 2021 Apr 15. Future Oncol. 2021. PMID: 33855865 Free article. Review.

4

Less toxic chemotherapy improves uptake of all lines of chemotherapy in advanced non-small-cell lung cancer: a 10-year retrospective population-based review.

Ho C, Ramsden K, Zhai Y, Murray N, Sun S, Melosky B, Laskin J. Ho C, et al. Among authors: melosky b. J Thorac Oncol. 2014 Aug;9(8):1180-6. doi: 10.1097/JTO.0000000000000225. J Thorac Oncol. 2014. PMID: 25157771 Free article.

5

Review of EGFR TKIs in Metastatic NSCLC, Including Ongoing Trials.

Melosky B. Melosky B. Front Oncol. 2014 Sep 15;4:244. doi: 10.3389/fonc.2014.00244. eCollection 2014. Front Oncol. 2014. PMID: 25309870 Free PMC article. Review.

6

Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer.

Melosky B. Melosky B. Front Oncol. 2014 Sep 29;4:256. doi: 10.3389/fonc.2014.00256. eCollection 2014. Front Oncol. 2014. PMID: 25325013 Free PMC article. Review.

7

Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer.

Melosky B. Melosky B. Front Oncol. 2017 Mar 20;7:38. doi: 10.3389/fonc.2017.00038. eCollection 2017. Front Oncol. 2017. PMID: 28373963 Free PMC article. Review.

8

Low Grade Neuroendocrine Tumors of the Lung.

Melosky B. Melosky B. Front Oncol. 2017 Jun 13;7:119. doi: 10.3389/fonc.2017.00119. eCollection 2017. Front Oncol. 2017. PMID: 28660170 Free PMC article. Review.

9

Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II-The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer.

Marginean EC, Melosky B. Marginean EC, et al. Among authors: melosky b. Arch Pathol Lab Med. 2018 Jan;142(1):26-34. doi: 10.5858/arpa.2017-0041-RA. Epub 2017 Nov 9. Arch Pathol Lab Med. 2018. PMID: 29120224 Free article. Review.

10

Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.

Marginean EC, Melosky B. Marginean EC, et al. Among authors: melosky b. Arch Pathol Lab Med. 2018 Jan;142(1):17-25. doi: 10.5858/arpa.2017-0040-RA. Epub 2017 Nov 16. Arch Pathol Lab Med. 2018. PMID: 29144791 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page